Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus

This study has been terminated.
Sponsor:
Information provided by:
Anza Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00800007
First received: November 26, 2008
Last updated: February 19, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)